SCHEMBL3617067

SCHEMBL3617067

CC(C)CC(C)O[PH](=O)O

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
RNPEP Q9H4A4 1/20 0.32
SLC7A5 Q01650 1/20 0.32
ANPEP P15144 3/20 0.31
LAP3 P28838 2/20 0.31
ERAP1 Q9NZ08 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11665295 0.83
SCHEMBL13885715 0.80
SCHEMBL11811827 0.79
SCHEMBL443578 0.79
SCHEMBL2898520 0.78 ALDH1A1 (0.32)
SCHEMBL11857046 0.77
SCHEMBL6890756 0.75
SCHEMBL27934464 0.75
SCHEMBL14580312 0.75
Phosphonic Acid SCHEMBL9705797 0.74 RNPEP (0.39) RNPEPSLC7A5ANPEPLAP3ERAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190263847-A1 METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND MARUZEN PETROCHEMICAL CO., LTD. (JP) 2019-08-29 US disclosed
EP-1544279-B1 LUBRICATING COMPOSITION NIPPON OIL CORP (JP) 2016-09-28 EP disclosed
CN-103173194-B Stable imidazoline solutions AFTON CHEMICAL CORP. (US) 2016-04-13 CN disclosed
US-7696137-B2 Lubricating oil compositions NIPPON OIL CORPORATION (JP) 2010-04-13 US disclosed
US-20050143266-A1 Lubricating oil compositions NIPPON OIL CORPORATION 2005-06-30 US disclosed
EP-1544279-A1 LUBRICATING COMPOSITION Nippon Oil Corporation (JP) 2005-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190263847-A1 METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND ORC3, OR10J3, ALK RNPEP 2587/4885SLC7A5 2585/4885ANPEP 2676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.